Factor XIII Activity and Antigen Levels in Patients with Coronary Artery Disease

Hans P. Kohler; Robert A. S. Ariëns; Michael W. Mansfield; Paul Whitaker; Peter J. Grant

doi:10.1055/s-0037-1615630

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2001; 85(03): 569-570
DOI: 10.1055/s-0037-1615630

Letters to the Editor

Schattauer GmbH

Factor XIII Activity and Antigen Levels in Patients with Coronary Artery Disease

Hans P. Kohler

¹Unit of Molecular Vascular Medicine, G-Floor, Martin Wing, Leeds General Infirmary, University of Leeds, UK

,

Robert A. S. Ariëns

¹Unit of Molecular Vascular Medicine, G-Floor, Martin Wing, Leeds General Infirmary, University of Leeds, UK

,

Michael W. Mansfield

¹Unit of Molecular Vascular Medicine, G-Floor, Martin Wing, Leeds General Infirmary, University of Leeds, UK

,

Paul Whitaker

¹Unit of Molecular Vascular Medicine, G-Floor, Martin Wing, Leeds General Infirmary, University of Leeds, UK

,

Peter J. Grant

¹Unit of Molecular Vascular Medicine, G-Floor, Martin Wing, Leeds General Infirmary, University of Leeds, UK

› Author Affiliations

Abstract

Full Text

References

References
1 Greenberg CS, Birckbichler PJ, Rice RH. Transglutaminases: multifunctional crosslinking enzymes that stabilize tissues. FASEB J 1991; 5: 3071-77.
2 Kohler HP, Stickland MH, Ossei-Gerning N, Carter C, Mikkola H, Grant PJ. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 1998; 79: 8-13.
3 Wartiovaara U, Perola M, Mikkola H, Tötterman K, Savolainen V, Penttilä A, Grant PJ, Tikkanen MJ, Vartiainen E, Karhunen PJ, Peltonen L, Palotie A. Association of FXIII Val34Leu with decreased risk of myocar-dial infarction in Finnish males. Atherosclerosis 1999; 142: 295-300.
4 Elbaz A, Poirier O, Canaple S, Chédru F, Cambien F, Amarenco P. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood 2000; 95: 586-91.
5 Kohler HP, Futers TS, Grant PJ. Prevalence of three common polymorphisms in the A-subunit gene of factor XIII in patients with coronary artery disease. Thromb Haemost 1999; 81: 511-5.
6 Catto AJ, Kohler HP, Coore J, Mansfield MW, Stickland MH, Grant PJ. Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood 1999; 93: 906-8.
7 Canavy I, Henry M, Morange PE, Tiret L, Poirier O, Ebagosti A, Bory M, Juhan-Vague I. Genetic polymorphisms and coronary artery disease in the south of France. Thromb Haemost 2000; 83: 212-16.
8 Balogh I, Szoke G, Karpati L, Wartiovaara U, Katona E, Komaromi I, Haramura G, Pfliegler G, Mikkola H, Musbek L. Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia. Blood 2000; 96: 2479-86.
9 Kohler HP, Ariens RAS, Whitaker P, Grant PJ. A common coding polymorphism in the factor XIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity. Thromb Haemost 1998; 80: 704.
10 Ariens RAS, Kohler HP, Mansfield MW, Grant PJ. Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals: Relation to gender, age, smoking and hypertension. Arterioscler Thromb Vasc Biol 1999; 19: 2012-16.
11 Trumbo TA, Maurer MC. Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII V34L mutation. J Biol Chem 2000; 275: 20627-631.
12 Mansfield WM, Kohler HP, Ariëns RAS, McCormack LJ, Grant PJ. Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and their first-degree relatives. Diabetes Care 2000; 23: 703-4.